Clinical Trials on 安全性和药代动力学 in Australia
总计13695个结果
-
Pfizer完全的
-
Foundation for Innovative New Diagnostics, Switzerland完全的
-
Pharmaxis完全的
-
Merck Sharp & Dohme LLC招聘中原发性骨髓纤维化 | 真性红细胞增多症 | 血小板增多症,必需的 | 骨髓纤维化 | 真性红细胞增多症后骨髓纤维化 | 原发性血小板增多症后骨髓纤维化澳大利亚, 新西兰
-
ImmusanT, Inc.完全的
-
Medtronic Cardiac Rhythm and Heart Failure完全的
-
Carmot Australia First Pty LtdCarmot Therapeutics, Inc.招聘中
-
University of MelbourneNational Health and Medical Research Council, Australia招聘中
-
National Institutes of Health Clinical Center (CC)完全的
-
Ji Xing Pharmaceuticals Australia Pty LtdNovotech (Australia) Pty Limited招聘中
-
Janssen-Cilag Pty Ltd完全的
-
Cellxpert Biotechnology Corp.Medigen Biotechnology Corporation完全的未明确的成人实体瘤,特定方案 | 黑色素瘤(皮肤)澳大利亚, 美国
-
The University of Western AustraliaRoyal Brisbane and Women's Hospital; Fremantle Hospital and Health Service; Royal Adelaide Hospital... 和其他合作者完全的
-
Monash UniversityThe Alfred; University of Sydney完全的
-
Arcturus Therapeutics, Inc.Novotech (Australia) Pty Limited; Seqirus招聘中
-
Zai Lab Pty. Ltd.未知
-
International Antiviral Therapy Evaluation CenterBoehringer Ingelheim完全的
-
University of SydneyNational Health and Medical Research Council, Australia完全的
-
PYC Therapeutics招聘中